The 34 references in paper Ya. Zverev F., V. Bryukhanov M., O. Talalaeva S., V. Lampatov V., A. Zharikov Yu., S. Talalaev V., Ya. Bulgakova S., Я. Зверев Ф., В. Брюханов М., О. Талалаева С., В. Лампатов В., А. Жариков Ю., С. Талалаев В., Я. Булгакова С. (2008) “О РОЛИ ПРОЦЕСОВ СВОБОДНО-РАДИКАЛЬНОГО ОКИСЛЕНИЯ В РАЗВИТИИ ЭКСПЕРИМЕНТАЛЬНОГО НЕФРОЛИТИАЗА // ON THE ROLE OF PROCESSES OF FREE RADICAL OXIDATION IN THE DEVELOPMENT OF EXPERIMENTAL NEPHROLITHIASIS” / spz:neicon:nefr:y:2008:i:1:p:58-63

1
Тиктинский ОЛ, Александров ВП. Мочекаменная бо­ лезнь. Питер, СПб., 2000; 3-12
(check this in PDF content)
2
Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115 (10): 2598-2608
(check this in PDF content)
3
Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris) 2005; 39 (6): 209-231
(check this in PDF content)
4
Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol 2007; 177: 31-38
(check this in PDF content)
5
Кадыров ЗА, Истратов ВГ, Сулейманов СИ. Некото­ рые вопросы этиологии и патогенеза мочекаменной болез­ ни. Урология 2006; 5: 98-101
(check this in PDF content)
6
Thamilselvan S, Selvan R. Effect of vitamin E and mannitol on renal calcium oxalate retention in experimental nephrolithiasis. Indian J Biochem Biophys 1997; 34 (3): 319­ 323
(check this in PDF content)
7
Thamilselvan S, Hackett RL, Khan SR. Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 1999; 10 [Suppl 14]: S452-S456
(check this in PDF content)
8
Thamilselvan S, Khan SR, Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 2003; 31 (1): 3-9
(check this in PDF content)
9
Huang HS, Chen CF, Chien CT, Chen J. Possible biphasic changes of free radicals in ethylene glycol-induced nephrolithiasis in rats. BJU Int 2000; 85 (9): 1143-1149
(check this in PDF content)
10
Huang HS, Ma MC, Chen J, Chen CF. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals. Neuronal Urodyn 2003; 22 (2): 176-182
(check this in PDF content)
11
Huang HS, Ma MC, Chen CF, Chen J. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 2003; 62 (6): 1123-1128
(check this in PDF content)
12
Aihara K, Byer KJ, Khan SR. Calcium phosphate- induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 2003; 64 (4): 1283-1291
(check this in PDF content)
13
Sumitra K, Pragasam V, Sakthivel R et al. Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 2005; 20 (7): 1407-1415
(check this in PDF content)
14
Tungsanga K, Sriboonlue P, Futrakul P et al. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 2005; 33 (1): 65-69
(check this in PDF content)
15
Khan SR, Hackett RL. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Scan Electron Microsc 1985; Pt 2: 759-774
(check this in PDF content)
16
Water R, Boeve ER, van Miert PP et al. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. Scanning Microsc 1996; 10 (2): 591-601
(check this in PDF content)
17
Khan SR. Animal models of kidney stone formation: an analysis. World J Urol 1997;15 (4): 236-243
(check this in PDF content)
18
Green ML, Hatch M, Freel RW. Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 2005; 289: F536-F543
(check this in PDF content)
19
Yamaguchi S, Wiessner JH, Hasegawa AT et al. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 2005; 12 (3): 290-298
(check this in PDF content)
20
Kumar S, Sigmon D, Miller T et al. A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 1991; 146 (5): 1384-1389
(check this in PDF content)
21
Bruijn WC, Boeve ER, van Run PR et al. Etiology of calcium oxalate nephrolithasis in rats. II. The role of the papilla in stone formation. Scanning Microsc 1995; 9 (1): 115-124
(check this in PDF content)
22
Khan SR. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. Scanning Microsc 1995; 9 (1): 89-100
(check this in PDF content)
23
Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003; 111(5): 602-605
(check this in PDF content)
24
Рытикова ОС, Брюханов ВМ, Зверев ЯФ, Госсен ИЕ. Роль перекисного окисления липидов в патогенезе непро­ должительной ишемии почки в эксперименте. Нефрология 2004; 8 (4): 115-116
(check this in PDF content)
25
Muthukumar A, Selvan R. Renal injury mediated calcium oxalate nephrolithiasis: role of lipid peroxidation. Ren Fail 1997; 19 (3): 401-408
(check this in PDF content)
26
Huang HS, Ma MC, Chen J, Chen CF. Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol 2002; 167 (6): 2584-2593
(check this in PDF content)
27
Selvan R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 2002; 30 (1): 35-47
(check this in PDF content)
28
Khan SR. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 2004; 98 (2): e55- e60
(check this in PDF content)
29
Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 2005; 33 (5): 349-357
(check this in PDF content)
30
Rashed T, Menon M, Thamilselvan S. Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 2004; 24 (5): 557-568
(check this in PDF content)
31
Huang HS, Chen J, Chen CF, Ma MC. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 2006; 70 (4): 699-710
(check this in PDF content)
32
Veena CK, Josephine A, Preetha SP et al. Renal peroxidative changes mediated by oxalate: the protective role of fucaidan. Life Sci 2006; 79 (19): 1789-1795
(check this in PDF content)
33
Thamilsulvan S, Menon M. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 2005; 96 (1): 117-126
(check this in PDF content)
34
Meimaridou E, Lobos E, Hothersall JS. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis. Am J Physiol Renal Physiol 2006; 291: F731-F740 Поступила в редакцию 11.12.2007 г.
(check this in PDF content)